Early solid form screening guide drug substance through drug product development

July 15, 2024

Remove from favorites

Add to favorites

The article discusses the importance of early solid form screening in drug development. This process involves identifying the most stable and effective solid form of a drug substance early in the development cycle. By conducting solid form screening early, pharmaceutical companies can make informed decisions about the best formulation for their drug product, which can significantly impact the drug's efficacy, stability, manufacturability, and intellectual property. The article highlights the key benefits of early solid form screening, including reducing the risk of late-stage failures, optimizing drug performance, and ensuring regulatory compliance.